• Kelley Anderson MD, FACC

  • Physician - Cardiology


    • Cardiology
    • 1000 North Oak Ave. 2D2 Marshfield, WI 54449

Education


1980 to 1983:
Fellowship, Cardiology, Stanford University School of Medicine, Stanford, CA
1978 to 1980:
Residency, Internal Medicine, University of Chicago-Hospitals, Michael Reese Hospital and Medical Center, Chicago, IL
1977 to 1978:
Internship, Internal Medicine, University of Chicago-Hospitals, Michael Reese Hospital and Medical Center, Chicago, IL
1973 to 1977:
MD, University of Rochester School of Medicine and Dentistry, Rochester, NY
1969 to 1973:
BA, Psychology, University of Rochester College of Arts and Sciences, Rochester, NY
1971 to 1972:
Hull University, Hull, England

Work Experience


2010 to Present:
Adjunct Clinical Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2000 to Present:
Cardiologist, Marshfield Clinic, Marshfield, WI
2000 to Present:
Attending Physician, Ministry Saint Joseph's Hospital, Marshfield, WI
2010 to 2012:
Director, Heart Failure Program, Marshfield Clinic, Marshfield, WI
2009 to 2011:
Medical Director Heart Care Services, Ministry Saint Joseph's Hospital, Marshfield, WI
2009 to 2011:
Chair, Department of Cardiology, Marshfield Clinic, Marshfield, WI
2001 to 2010:
Clinical Associate Professor of Medicine, University of Wisconsin Medical School, Madison, WI
1994 to 2000:
Director, Cardiac Electrophysiology Program, University of Pittsburgh Medical Center and Pittsburgh Veterans Administration Medical Center, Pittsburgh, PA
1994 to 2000:
Associate Professor, University of Pittsburgh School of Medicine, Pittsburgh, PA
1991 to 1994:
Associate Professor, University of Utah School of Medicine, Salt Lake City, UT
1983 to 1994:
Director, Clinical Electrophysiology Laboratory and Cardiac Research Laboratory, University of Utah School of Medicine, Salt Lake City, UT
1983 to 1991:
Assistant Professor, University of Utah School of Medicine, Salt Lake City, UT

Select Publications


  • Anderson KP, DeCamilla J, Moss AJ. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. CIRCULATION. 1978 May;57(5):890-897.
    PubMed ID: 639211
  • Anderson KP, Stinson EB, Mason JW. Surgical exclusion of focal paroxysmal atrial tachycardia. Am J Cardiol. 1982 Mar;49(4):869-874.
    PubMed ID: 7064836
  • Nash E, Beinlich I, Anderson KP, Mason JW. A computerized electrophysiology analysis system. Computers in Cardiology. 1982; :1-4.
  • Anderson KP, Stinson EB, Derby GC, Oyer PE, Mason JW. Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Analysis of 17 patients. Am J Cardiol. 1983 Mar;51(5):811-816.
    PubMed ID: 6681930
  • Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. CIRCULATION. 1983 Jul;68(1):88-94.
    PubMed ID: 6851057
  • Anderson KP, Mason JW. Surgical management of ventricular tachyarrhythmias. Clin Cardiol. 1983 Sep;6(9):415-425.
    PubMed ID: 6354539
  • Anderson KP, Swerdlow CD, Mason JW. Entrainment of ventricular tachycardia. Am J Cardiol. 1984 Jan;53(2):335-340.
    PubMed ID: 6695734
  • Anderson KP. Sudden death in patients with hypertrophic cardiomyopathy. Cardiovasc Rev and Rep. 1984;5 :363-377.
  • Anderson KP, Mason JW. Mechanisms of ventricular tachycardia. Le Journal International de Medicine. 1984;9 :12-19.
  • Anderson KP. Sudden death, hypertension, and hypertrophy. J Cardiovasc Pharmacol. 1984;6(Suppl 3):S498-S503.
    PubMed ID: 6208419
  • Mason JW, Stinson EB, Oyer PE, Winkle RA, Hunt S, Anderson KP, Derby GC. The mechanisms of ventricular tachycardia in humans determined by intraoperative recording of the electrical activation sequence. Int J Cardiol. 1985 Jun;8(2):163-175.
    PubMed ID: 4008106
  • Anderson KP, Stinson EB, Block PJ, Derby GC, Oyer PE, Ross DL, Popp RL, Mason JW. Epicardial mapping in patients with hypertrophic cardiomyopathy. J Applied Cardiol. 1986;1 :285-307.
  • Anastasiou-Nana MI, Anderson JL, Nanas JN, Lutz JR, Smith RA, Anderson KP, Crapo RO, Call NB. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. Can J Cardiol. 1986 May;2(3):138-145.
    PubMed ID: 2941121
  • Green LS, Lux RL, Freedman RA, Anderson KP, Haws CW. Body surface QRST areas and therapy for long QT syndrome. Clin Res. 1986; :34-2D304A.
  • Freedman RA, Anderson KP, Mason JW. Electrophysiologic studies in patients with ventricular tachycardia. Annu Rev Med. 1986;37 :1-12.
    PubMed ID: 3518600
  • Anderson KP, Freedman RA, Mason JW. Electrophysiologic study: when is it appropriate? Drug Therapy. 1986;16 :111-126.
  • Mason JW, Anderson KP, Freedman RA. Techniques and criteria in electrophysiologic study of ventricular tachycardia. CIRCULATION. 1987 Apr;75(4 Pt 2):III125-133.
    PubMed ID: 3549047
  • Freedman RA, Anderson KP, Green LS, Mason JW. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol. 1987 Jan;59(1):168-169.
    PubMed ID: 3812231
  • Anderson KP, Freedman RA, Mason JW. Sudden death in idiopathic dilated cardiomyopathy. Ann Intern Med. 1987 Jul;107(1):104-106.
    PubMed ID: 3592423
  • Anderson KP. The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators. CIRCULATION. 1989 Jun;79(6):1354-1360.
    PubMed ID: 2655967
  • Anderson KP, Walker R, Dustman T, Lux RL, Ershler PR, Kates RE, Urie P. Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo. CIRCULATION. 1989 Apr;79(4):948-958.
    PubMed ID: 2924420
  • Lux RL, Ershler PR, Anderson KP, Mason JW. Rapid localization of accessory pathways in WPW syndrome using unipolar potential mappiong. Proc of IEEE Eng, Med & Biol Soc. 1989; :195-196.
  • Anderson KP, Walker R, Lux RL, Ershler PR, Menlove R, Williams MR, Krall R, Moddrelle D. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart. CIRCULATION. 1990 Mar;81(3):1024-1038.
    PubMed ID: 2155070
  • Anderson KP. Sudden death in patients with hypertrophic cardiomyopathy: recent developments. Cardiovasc Rev Rep. 1990;11 :66-75.
  • Anderson KP, Lux RL, Dustman T. Comparison of QRS morphologies of spontaneous premature ventricular complexes and ventricular tachycardia induced by programmed stimulation. AMERICAN HEART JOURNAL. 1990 Jun;119(6):1302-11.
    PubMed ID: 1693809
  • Anderson KP, Walker R, Ershler PR, Fuller M, Dustman T, Menlove R, Karwandee SV, Lux RL. Determination of local myocardial electrical activation for activation sequence mapping. A statistical approach. Circ Res. 1991 Oct;69(4):898-917.
    PubMed ID: 1934344
  • Anderson KP, Walker R, Fuller M, Dustman T, Ershler PR, Lux RL. Criteria for local myocardial electrical activation: effects of electrogram characteristics. IEEE Trans Biomed Eng. 1993 Feb;40(2):1-13.
    PubMed ID: 8319968
  • Anderson KP. Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators. CIRCULATION. 1993 Feb;87(2):323-329.
    PubMed ID: 8425281
  • Anderson KP. Management of ectopic atrial tachycardia. J Am Coll Cardiol. 1993 Jul;22(1):93-94.
    PubMed ID: 8509570
  • Anderson KP, Walker R, Urie P, Ershler PR, Lux RL, Karwandee SV. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1993 Jul;92(1):122-140.
    PubMed ID: 8325977
  • Anderson KP. A randomized comparison of electrophysiologic study to electrocardiographic monitoring for prediction of antiarrhythmic drug efficacy in patients with ventricular tachyarrhythmias. ESVEM Investigators. N Engl J Med. 1993;329 :445-451.
  • Anderson KP. A comparison of seven antiarrhythmic drugs in patients with ventricular tacharrhythmias. ESVEM Investigators. N Engl J Med. 1993;329 :452-458.
  • Anderson KP. The electrophysiologic study versus electrocardiographic monitoring trial and the role of electrophysiologic study in the management of pateints with ventricular tachyarrhythmias. J Ambulatory Monitoring. 1995;8 :185-196.
  • Anderson KP, Schloss EJ. The ESVEM trial tells us what we don't know (letter). CIRCULATION. 1995; :3144.
  • Anderson KP, Walker R, Dustman T, Fuller M, Mori M. Spontaneous sustained ventricular tachycardia in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1995 Aug;26(2):489-96.
    PubMed ID: 7541813
  • Anderson KP, Bigger JT, Freedman RA. The clinical significance of nonsustained ventricular tachycardia in patients with sustained centricular tachyarrhythmias. Ann Noninvasive Electrocardiol. 1996;1 :33-43.
  • Anderson KP, Bigger JT, Freedman RA. Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram. Prog Cardiovasc Dis. 1996 May;38(6):463-488.
    PubMed ID: 8638028
  • Anderson KP, Hartz V, Hahn EA, Moon TE. Design and analysis of the ESVEM Trial. Prog Cardiovasc Dis. 1996 May;38(6):489-502.
    PubMed ID: 8638029
  • Anderson KP, Mori M. The clinical significance of nonsustained ventricular tachycardia in patients with sustained ventricular tachyarrhythmias. Ann Noninvasive Electrocardiol. 1996;1 :33-43.
  • Anderson KP, Bigger JT, Hammill SC, Lamas GA, Lazzara A, Malik M, Packer DL, Roden DM. Who needs a journal? Cardiac Electrophysiol Rev. 1997;1 :1.
  • Wanless RS, Anderson KP, Joy M, Joseph SP. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Am Heart J. 1997 Apr;133(4):441-446.
    PubMed ID: 9124166
  • Shusterman V, Anderson KP, Barnea O. Spontaneous skin temperature oscillations in normal human subjects. Am J Physiol. 1997 Sep;273(3 Pt 2):R1173-R1181.
    PubMed ID: 9321901
  • Shusterman V, Konety S, Flanigan S, Shah SI, Fahrig S, Gottipaty V, Anderson KP. Short-term changes in RR and QT-intervals are related to the rate and duration of ventricular tachycardia. CIRCULATION. 1997;96 (Suppl - I) :I-581.
  • Gold MR, Kavesh NG, Anderson KP, Bloomfield DM, Estes NMark, Michaud GF, Wilber DJ, Cohen RJ, Rosenbaum DS. Correlation of T-wave alternans during exercise with the induction of ventricular tachycardia. PACE Pacing Clin Electrophysiol. 1998;21 :861.
  • Shusterman V, Li C, Aysin B, Brode S, Fahrig S, Gottipaty V, Schwartzman D, Weiss R, Anderson KP. ircadian changes in the energy distribution of wavelet-transformed heart rate variability (abstr). PACE Pacing Clin Electrophysiol. 1998;21 :887.
  • Weiss R, London B, McNamara DG, Shusterman V, Buetikofer JA, Brode S, Fahrig S, Gottipaty V, Schwartzman D, Anderson KP. Familial occurrence of right bundle branch block, ST elevation and arrhythmia susceptibility (abstr). PACE Pacing Clin Electrophysiol. 1998;21 :939.
  • Shusterman V, Aysin B, Beigel A, Brode S, Fahrig S, Gottipaty V, Schwartzman D, Weiss R, Anderson KP. Do slow variations in heart rate predict spontaneous initiation of ventricular tachycardia? PACE Pacing Clin Electrophysiol. 1998;21 :948.
  • Schwartzman D, Michele JJ, Trankiem CT, Ren JF, Gottipaty V, Anderson KP. Radiofrequency energy titration for atrial ablation: prospective comparison of thermometry versus electrogram amplitude reduction (abstr). PACE Pacing Clinical Electrophysiol. 1998;21 :849.
  • Hunn RH, Ashbaugh TJ, Calderini M, Anderson KP. Multiple inappropriate shocks precipitated by interrogation of an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 1998 Jun;21(6):1329-1330.
    PubMed ID: 9633083
  • Shusterman V, Aysin B, Gottipaty V, Weiss R, Brode S, Schwartzman D, Anderson KP. Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. J Am Coll Cardiol. 1998 Dec;32(7):1891-1899.
    PubMed ID: 9857869
  • Shusterman V, Aysin B, Shah IS, Flanigan S, Anderson KP. Autonomic nervious system effects on ventricular repolarization and RR interval variability during head-up tilt. Computers in Cardiology. 1998;25 :717-720.
  • Brode S, Singh B, Anderson KP. Sotalol. Cardiac Electrophysiol Rev. 1998;2 :211-214.
  • Brode S, Anderson KP. Moricizine. Cardiac Electrophysiol Rev. 1998;2 :197-199.
  • Schwartzman D, Fischer DJ, Spencer EP, Anderson KP. Linear radiofrequency atrial lesions deployed using an irrigated electrode: electrical and histological evolution (abstr). CIRCULATION. 1998;98 (Supp) :1567-68.
  • Anderson KP, Shusterman V, Aysin B, Brode S, Gottipaty V, Schwartzman D. Mismatch of tonic and phasic sympathetic activity precedes spontaneous ventricular tachycardia. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998;31(90A)
  • Anderson KP, Shusterman V, Aysin B, Weiss R, Brode S, Gottipaty V. Distinctive RR dynamics preceding two modes of onset of spontaneous sustained ventricular tachycardia. (ESVEM) Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring. J Cardiovasc Electrophysiol. 1999 Jul;10(7):897-904.
    PubMed ID: 10413369
  • Anderson KP, Shusterman V, Brode S, Gottipaty V, Schwartzman D, Weiss R. Noninvasive testing for selection of patients for electrophysiologic study. Ann Noninvasive Electrocardiol. 1999;4 :434-442.
  • Shusterman V, Beigel A, Shah IS, Aysin B, Weiss R, Gottipaty V, Schwartzman D, Anderson KP. Changes in autonomic activity and ventricular repolarization. J Electrocardiol. 1999;32 :185-192.
  • Gold MR, Bloomfield DM, Anderson KP, El-sherif NE, Wilber DJ, Groh WJ, Estes NMark, Kaufman ES, Greenberg ML, Rosenbaum DS. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000 Dec;36(7):2247-2253.
    PubMed ID: 11127468
  • Shusterman V, Shah SI, Beigel A, Anderson KP. Enhancing the precision of ECG baseline correction: selective filtering and removal of residual error. Comput Biomed Res. 2000 Apr;33(2):144-160.
    PubMed ID: 10854121
  • Kadish A, Quigg R, Schaechter A, Anderson KP, Estes M, Levine J. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol. 2000 Mar;23(3):338-343.
    PubMed ID: 10750134
  • Shusterman V, Aysin B, Weiss R, Brode S, Gottipaty V, Schwartzman D, Anderson KP. Dynamics of low-frequency R-R interval oscillations preceding spontaneous ventricular tachycardia. Am Heart J. 2000 Jan;139(1 Pt 1):126-133.
    PubMed ID: 10618573
  • Anderson KP. Pharmacologic therapy of ventricular tachycardia: management of cardiac arrhythmias. Humana Press. 2000; :331-357.
  • Anderson KP, Shusterman V, Flanigan S. Holter Monitoring. Atlas of Office Procedures: Cardiovascular Diseases. 2000;3 :335-352.
  • Anderson KP, Vidaillet HJ, Josephson ME. A gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. 2001 Oct;345(14):1063-1064.
    PubMed ID: 11586962
  • Anderson KP. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001 Sep;345(11):837; author reply 838-839.
    PubMed ID: 11556310
  • Shusterman V, Aysin B, Anderson KP, Beigel A. Multidimensional rhythm disturbances as a precursor of sustained ventricular tachyarrhythmias. Circ Res. 2001 Apr;88(7):705-712.
    PubMed ID: 11304493
  • Hayes JJ, Anderson KP, Sharma PP, Smith PN, Vidaillet HJ, Maassen KA. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA. 2002;288(24):3115-3123.
  • Anderson KP. The future of cardiac electrophysiology review. Cardiac Electrophysiol Rev. 2003 Dec;7(4):311.
    PubMed ID: 15168682
  • Anderson KP. Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances. Ann Noninvasive Electrocardiol. 2003 Jan;8(1):75-89.
    PubMed ID: 12848817
  • Anderson KP. Lipid-lowering therapy for prevention of ventricular tachyarrhythmias. J Am Coll Cardiol. 2003 Jul;42(1):88-92.
    PubMed ID: 12849665
  • Sharma PP, Osorio HJ, Greenlee RT, Hayes JJ, Smith PN, Anderson KP, Vidaillet HJ. Prevalence of patients with myocardial infarction and reduced left ventricular ejection fraction: impact of the MADIT II study in the general population. J Am Coll Cardiol. 2003;41(6 Suppl):96A.
  • Sharma PP, Greenlee RT, Hayes JJ, Smith PN, Anderson KP, Vidaillet HJ. How many patients with ischemic cardiomyopathy in the U.S. are eligible for ICD placement? Impact of the new CMS Coverage Guidelines. Heart Rhythm Society Annual Scientific Sessions. Heart Rhythm. 2004;1(1S):S180-181.
  • Sharma PP, Greenlee RT, Hayes JJ, Anderson KP, Vidaillet HJ. Generalizability of the MADIT II trial: comparison of study participants versus eligible patients in a general population. CIRCULATION. 2004 Nov;110(17):III827.
  • Kadish A, Dyer A, Daubert JP, Quigg R, Estes NMark, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH., for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New Engl J Med. 2004 May;350(21):2151-2158..
    PubMed ID: 15152060
  • Passman R, Anderson KP, Subacius H, Schaechter A, Howard A, Calkins H, Kadish A. For the DEFINITE investigators superior quality of life in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillators: results from the DEFINITE study. CIRCULATION. 2004;110 :III-625.
  • Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol. 2005 Nov;14(2):71-78.
    PubMed ID: 16374553
  • Kadish A, Schaechter A, Subacius H, Thattassery E, Sanders WE, Anderson KP, Dyer A, Goldberger J, Levine J. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Jun;47(12):2477-2482.
    PubMed ID: 16781376
  • Sharma PP, Greenlee RT, Anderson KP, Chyou P, Osorio HJ, Smith PN, Hayes JJ, Vidaillet HJ. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: Relation to the second multicenter automatic defibrillator implantation trial. J Interv Card Electrophysiol. 2007 Sep;19(3):157-164.
    PubMed ID: 17805953
  • Anderson KP. Risk assessment for defibrillator therapy: Il Trittico. J Am Coll Cardiol. 2007 Sep;50(12):1158-1160.
    PubMed ID: 17868807
  • Anderson KP. The changing epidemiology of ventricular arrhythmias. CARDIOLOGY CLINICS. 2008 Aug;26(3):321-333.
    PubMed ID: 18538182
  • Anderson KP. Health status assessment tools: natural components of cardiac resynchronization therapy? Pacing Clin Electrophysiol. 2009 Oct;32(10):1257-8.
    PubMed ID: 19732356
  • Anderson KP. Estimates of implantable cardioverter-defibrillator complications; caveat emptor. CIRCULATION. 2009 Mar;119(8):1069-71.
    PubMed ID: 19255352
  • Anderson KP. Closing the gaps in atrial fibrillation ablation: the role of protected electrical connections. J Cardiovasc Electrophysiol.. 2011 Feb;22(2):160-2.
    PubMed ID: 21040097
  • Anderson KP. Ablation for atrial fibrillation: what are acceptable levels of experience, efficacy, and complications? J Interv Card Electrophysiol. 2012 Aug;34(2):125-8.
    PubMed ID: 22403043
  • Anderson KP. Prevention of Arrhythmic Death in Valvular Heart Disease: Beware the Implantable Defibrillator Paradox. J Cardiovasc Electrophysiol.. 2012 Dec;23(12):1333-5.
    PubMed ID: 22882158
  • Anderson KP. Programmed electrical stimulation for risk assessment in brugada syndrome time to change the guidelines? JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2012 Jan;59(1):46-8.
    PubMed ID: 22192667
  • Anderson KP. Biological Clocks and Ventricular Tachyarrhythmias. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2014 Apr;2(14):S0735-1097.
    PubMed ID: 24747103